Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and TAAs. More
Peptide vaccine to confer immunity to MUC1-expressing tumors More
The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More
A model for studying T cell development, immunological based gastrointestinal disorders More
In order to, to achieve the most active action of body energy, it is known that pH of water-containing blood should be maintained at an alkaline of 7.35 to 7.45. More
A method of identifying a ligand as a candidate for incorporation into a pharmaceutical composition that modulates antigen presenting cell activity More
Biomimic prenatal and postnatal maternal-to-infant transfer of clinical monosaccharides for improved neurologic development and immunologic functions More
Derivatives of Butyric Acid and Uses Thereof - treatment of autoimmune More
Compositions and methods for using HMGN and its derivatives as immunoadjuvants in combination, as mixtures or as chemical conjugates, with microbial or tumor antigens More
Methods of producing a population of purified non-alloreactive antigen-specific T cells that recognize an antigen of interest More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
Aug 2007 - 345 pages - $2,875
Dec 2010 - 37 pages - $500
Jan 2010 - $75
Jan 2011 - 34 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $250
Apr 2011 - 75 pages - $3,800
Dec 2010 - 22 pages - $500
Oct 2011 - 113 pages - $2,795
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us